Relypsa Inc
DelistedCIK 1416792fmd_1X0FD9CJ6FKMQ71ZEFBHPGQF8HManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2016, 15 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|
| Research and development | 36 | 59 | 50 | 93 |
| Selling, general and administrative | – | 12 | 28 | 103 |
| Total operating expenses | 43 | 71 | 78 | 196 |
| Operating income | (43) | (71) | (78) | (178) |
| Interest expense | 0 | 1 | 2 | 2 |
| Other non-operating income (expense) | (0) | (1) | 0 | 1 |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income | (44) | (74) | (80) | (179) |
| Net income to common shareholders | (62) | (81) | (80) | (179) |